BRITTANY BILBERRY: Open Payments
NPI 1497352439 · GARDEN CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 67 payments from 13 companies in 2025. Trend: 2023 $455 · 2024 $509 · 2025 $1,156
Food & beverage: $994Education: $162
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $248 |
| E.R. Squibb & Sons, L.L.C. | 13 | $194 |
| ABBVIE INC. | 13 | $178 |
| UCB, Inc. | 10 | $141 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| LEO Pharma Inc. | 3 | $57 |
| Amgen Inc. | 3 | $47 |
| GENZYME CORPORATION | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $35 |
Products named: TREMFYA, Sotyktu, DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, OTEZLA, COSENTYX.
Industry payments across KS — which companies pay providers there.
